MedTrace Logo

Identification of Novel Genetic Factors That Contribute to Risk for Breast Cancer

NCT00276120 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4385

Last updated 2023-01-25

No results posted yet for this study

Summary

The purpose of this study is to identify novel genetic factors which distinguish breast cancer in younger women compared to older women. By identifying these novel genetic factors we believe more specific therapies can be developed and breast cancer may be prevented among women with an increased cancer risk. A woman does not have to live in St. Louis to participate.

Conditions

Sponsors & Collaborators

  • Barnes-Jewish Hospital

    collaborator OTHER

  • Ohio State University Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Amanda Toland, PhD · The Ohio State University Comprehensive Cancer Center

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-03-31
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00276120 on ClinicalTrials.gov